Phase 4 Type 2 Diabetes Trial, By Invitation NCT07452913 Sponsor: Bahria University Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Phase 4 Type 2 Diabetes Trial, By Invitation

NCT07452913
By Invitation Phase 4

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Men and women are eligible to participate.
  • Participants must be between 30 and 55 years of age.
  • Blood sugar control levels (measured by a test called HbA1c) must fall within a specific range — at or above 8.5 but below 10 (confirm with trial site for exact units used).
  • Body weight relative to height (BMI) must fall within a specific range — above 18.5 but below 29.9, measured using Asian weight guidelines.
  • Participants must not have previously been treated with diabetes medication (treatment naïve).
  • People with or without abnormal cholesterol or blood fat levels may be eligible.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose HbA1c blood sugar level is above 10 mmol/mol.
  • People with a BMI above 30 kg/m².
  • People who are pregnant or currently breastfeeding.
  • People who have certain long-term or serious health conditions, such as high blood pressure, thyroid problems, liver disease, or kidney disease.
  • People who have a known allergy or bad reaction to any of the following medications: Metformin, Empagliflozin, Sitagliptin, or Linagliptin.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Phase 4
Sponsor
Bahria University
Registry
ClinicalTrials.gov
Start date
1 January 2026
Est. completion
30 March 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Primary Outcome

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov